Hemab Therapeutics Holdings, Inc. Common Stock holds $175.3M in total assets. Shareholders' equity is -$198.6M against $1.1M in total debt. Cash and equivalents total $49.9M. The current ratio is 12.85 and debt-to-equity is -0.005.
| Metric | Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|
| Operating lease liabilities, non-current | — | — | $573.0K | $519.0K |
| Total liabilities | — | — | $11.3M | $13.7M |